Le Lézard
Classified in: Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

Electromed, Inc. Schedules its Second Quarter Fiscal 2023 Financial Results Conference Call for February 14, 2023 at 5:00 p.m. ET


Electromed, Inc. ("Electromed" or the "Company") (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2023 second quarter ended December 31, 2022, on Tuesday, February 14, 2023 after the close of the stock market, and host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results.

Interested parties may participate in the call by dialing (877) 407-0789 (Domestic) or (201) 689-8562 (International).

The live conference call webcast will be accessible in the Investor Relations section of Electromed's web site and directly via the following link: https://viavid.webcasts.com/starthere.jsp?ei=1596017&tp_key=9bc6fba7a8

For those who cannot listen to the live broadcast, a replay will be available by dialing (844) 512-2921 (Domestic) or (412) 317-6671 (International) and referencing the replay pin number 13736069. Additionally, an online replay will be available in the Investor Relations section of Electromed's web site at: http://investors.smartvest.com/.


These press releases may also interest you

at 19:35
Regenx Provides Bi-Weekly Update on Status of Management Cease Trade Order
Regenx Tech Corp., (the "Company" or "Regenx") is providing this bi-weekly update on the status of the application to the Alberta Securities Commission for a management cease trade order, under National Policy 12-203 -?? Management Cease Trade...

at 19:14
KADESTONE CAPITAL CORP. REPORTS Q4 AND FULL YEAR 2023 FINANCIAL RESULTS
Kadestone Capital Corp. ("Kadestone" or the "Company") , a vertically integrated property company today announced its financial results for the year ended December 31, 2023....

at 19:05
Appili Therapeutics Announces Additional Bridge Loan from Bloom Burton & Co.
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
Greenberg Traurig's David Dykeman and Roman Fayerberg to Present at DeviceTalks Boston
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:54
ADSK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Autodesk, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Autodesk, Inc. ("Autodesk" or "the Company") and certain of its officers....

at 18:54
CLIFFSIDE CAPITAL LTD. ANNOUNCES FISCAL 2023 FINANCIAL RESULTS
Cliffside Capital Ltd. ("Cliffside" or the "Company")  is pleased to announce financial results for the year ended December 31, 2023. The Company reported the following for 2023 compared with the prior year: Decline in gross finance receivables by...

More news about Business...


News published on and distributed by: